EcoDrugPlus


Keyword(s):	Human Neurotoxin
Molecule Category	Salt-form
EPA CompTox	DTXSID40893872

Keyword(s):

Human Neurotoxin

Molecule Category

Salt-form

EPA CompTox

DTXSID40893872


InChI Key	QGWDKKHSDXWPET-UHFFFAOYSA-E
Smiles	[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[O--].[Bi+3].[Bi+3].[Bi+3].[Bi+3].[Bi+3].[O-]N(=O)=O.[O-]N(=O)=O.[O-]N(=O)=O.[O-]N(=O)=O
InChI	InChI=1S/5Bi.4NO3.9H2O.O/c;;;;;42-1(3)4;;;;;;;;;;/h;;;;;;;;;91H2;/q5+3;4-1;;;;;;;;;;-2/p-9

InChI Key

QGWDKKHSDXWPET-UHFFFAOYSA-E

Smiles

[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[O--].[Bi+3].[Bi+3].[Bi+3].[Bi+3].[Bi+3].[O-]N(=O)=O.[O-]N(=O)=O.[O-]N(=O)=O.[O-]N(=O)=O

InChI

InChI=1S/5Bi.4NO3.9H2O.O/c;;;;;4*2-1(3)4;;;;;;;;;;/h;;;;;;;;;9*1H2;/q5*+3;4*-1;;;;;;;;;;-2/p-9

Property Name	Value
Molecular Formula	Bi5H9N4O22
Molecular Weight	1461.87
AlogP	-4.57
Hydrogen Bond Acceptor	21.0
Polar Surface Area	563.3
Heavy Atoms	31.0

Property Name

Value

Molecular Formula

Bi5H9N4O22

Molecular Weight

1461.87

AlogP

-4.57

Hydrogen Bond Acceptor

21.0

Polar Surface Area

563.3

Heavy Atoms

31.0

Resources	Reference
CAS NUMBER	1304-85-4
NORMAN SUSDAT

Resources

Reference

CAS NUMBER

1304-85-4

NORMAN SUSDAT


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

BISMUTH HYDROXIDE NITRATE OXIDE (BI5(OH)9(NO3)4O)

Structure

Physicochemical Descriptors

Cross References

BISMUTH HYDROXIDE NITRATE OXIDE (BI5(OH)​9(NO3)​4O)

Structure

Physicochemical Descriptors

Cross References

BISMUTH HYDROXIDE NITRATE OXIDE (BI5(OH)9(NO3)4O)